Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome

NCT05183178 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

16000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Prasugrel 10 mg p.o
DRUG: Ticagrelor 90 mg

Sponsor

Vastra Gotaland Region

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]